Lipids

Resource Center

FDA Alerts

Lipids

FDA Approves New Dosing Option for Praluent

04/25/2017

The FDA has approved a new, monthly dosing option for the PCSK9-inhibitor Praluent (alirocumab).

04/25/2017

Research Summaries

Research Summary

Among Patients With Atherosclerotic Cardiovascular Disease Who Are Eligible For High-Intensity Statins, Most Are Not Using Them

01/26/2024

Jessica Ganga

Researchers evaluated whether patients with atherosclerotic cardiovascular disease (ASCVD) are utilizing high-intensity statins in their routine care of the disease.

01/26/2024

Research Summary

USPSTF Releases Recommendation for Screening for Lipid Disorders in Children, Adolescents

09/29/2023

Jessica Ganga

The US Preventive Task Force (USPSTF) released its updated recommendations for screening children and adolescents for lipid disorders.

09/29/2023

Research Summary

Research Summary

Can Pitavastatin Lower the Risk of Cardiovascular Events in Patients with HIV?

08/15/2023

Anthony Calabro, MA

Patients with HIV have up to double the risk of atherosclerotic cardiovascular disease compared with the general population.

08/15/2023

Mediterranean Diet

Green-Mediterranean Diet Reduces Two Times Amount of Visceral Adipose Tissue Compared to Mediterranean Diet Alone

12/28/2022

The researchers compared the effects of the traditional Mediterranean diet to the green-Mediterranean diet on visceral adipose tissue loss.

12/28/2022

Lipids

GOULD Results Show That Crucial Lipid-Lowering Drugs Are Underused

12/30/2019

The GOULD study is a multicenter, observational registry of patients with atherosclerotic cardiovascular disease in which the primary endpoint was to describe LDL-C treatment patterns over time in patients...

12/30/2019

October 2024

Current Issue

October 2024

Volume 64

Issue 9